Home/ Stocks/ SCNX

Scienture Holdings, Inc. Common Stock

SCNX XNAS

$0.40 -0.02 (-5.04%) ▼ 15-min delayed

Open

$0.41

High

$0.42

Low

$0.40

Volume

435.5K

Market Cap

$16.25M

About Scienture Holdings, Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 9 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$431.6K	$-41,512,264	$-2.70
FY 2025	$431.6K	$-41,512,264	$-2.70
Q3 2025	$590.0K	$-3,607,361	$-0.19
Q2 2025	$0	$-6,720,573	$-0.48

Related Market News

No specific coverage for SCNX yet. Check out our latest market news or earnings calendar.

Get SCNX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Scienture Holdings, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.